Free

I have read and agree to Ardmore Institute of Health’s HIPAA Notice of Privacy Practices, Terms of Service, Privacy Policy and Cookie Policy as detailed in the links below.

And, I agree to consult my physician or healthcare provider under the following circumstances:

If I choose to implement lifestyle changes recommended in any content contained in Ardmore Institute of Health’s websites, such as changes to my diet or exercise regimens, I understand that I should consult with my physician or healthcare provider before making such changes. The recommendations and suggestions offered by Ardmore Institute of Health’s content are not a substitute for medical advice.

An account already exists with this email address. Is this you?

Sign in

Prescribing GLP-1 RA Medications and Lifestyle Habits to Maximize Patient Success CME

Upon completion of this activity, participants will be able to:

  • Explain the mechanisms of action, therapeutic effects, and limitations of GLP-1 receptor agonists.
  • Develop individualized treatment plans that integrate GLP-1 receptor agonist therapy with lifestyle interventions to support sustainable weight loss and improve management of related comorbidities.
  • Apply best practices in medication titration, side effect management, and patient counseling to support safe and sustainable care.

This continuing medical education (CME) activity provides an in-depth, evidence-based review of GLP-1 receptor agonist (GLP-1 RA) medications in treating obesity, emphasizing their clinical application alongside lifestyle medicine. Presented by Dr. Bonnet, a board-certified physician in family, sports, obesity, and lifestyle medicine, the session explores prescribing strategies, expected outcomes, patient counseling, and real-world considerations that family physicians commonly encounter.

The AAFP has reviewed Prescribing GLP-1 RA Medications and Lifestyle to Maximize Patient Success and deemed it acceptable for up to 2.00 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 06/12/2026 to 06/12/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

HIPAA Notice of Privacy Practices Terms of Service Privacy Policy Cookie Policy